jRCT2031210637已完成不适用
An Open-label, Multi-center Extension Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants with Moderate to Severe Crohn's Disease or Moderate to Severe Ulcerative Colitis
Bristol-Myers Squibb0 个研究点目标入组 15 人开始时间: 2022年3月22日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Previously completed OLE treatment in 1 of the parent CD or UC studies
排除标准
- •Any disease or medical condition that, in the opinion of the investigator, would make the participant unsuitable for this study, would interfere with the interpretation of participant safety or study results, or is considered unsuitable by the investigator for any other reason.
结局指标
主要结局
-
To assess the safety and tolerability of long-term use of BMS-986165(Deucravacitinib)
次要结局
未报告次要终点
研究者
相似试验
招募中
不适用
Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE
(POETYK SLE-2) (IM011-247)Systemic Lupus ErythematosusjRCT2011230001Bristol-Myers Squibb490
招募中
不适用
Investigation of the usefulness of deucravacitinib in early onset psoriasisPsoriasis vulgarisjRCTs041240089100
进行中（未招募）
不适用
Efficacy and Safety of Deucravacitinib in Adults with Alopecia Areata (IM011-134)Alopecia AreatajRCT2031220610Bristol-Myers Squibb9
已完成
2 期
A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative ColitisUlcerative ColitisCrohn DiseaseNCT04877990Bristol-Myers Squibb67
终止
不适用
Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar PustulosisPalmoplantar PustulosisNCT07000630Peking University First Hospital3